Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview

Patients with hepatocellular carcinoma (HCC) face a common type of cancer, which is amongst the most deadly types of cancer worldwide. The therapeutic options range from curative resection or ablation to loco regional therapies in palliative setting and last but not least, systemic treatment. The la...

Descripción completa

Detalles Bibliográficos
Autores principales: van Doorn, Diederick J., Takkenberg, Robert Bart, Klümpen, Heinz-Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821931/
https://www.ncbi.nlm.nih.gov/pubmed/33374927
http://dx.doi.org/10.3390/ph14010003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821931/
https://www.ncbi.nlm.nih.gov/pubmed/33374927
http://dx.doi.org/10.3390/ph14010003

Ejemplares similares